1. 2-Year Outcomes After Stenting of Lipid-Rich and Nonrich Coronary Plaques
- Author
-
Yamamoto, Myong Hwa, Maehara, Akiko, Stone, Gregg W, Kini, Annapoorna S, Brilakis, Emmanouil S, Rizik, David G, Shunk, Kendrick, Powers, Eric R, Tobis, Jonathan M, Maini, Brijeshwar S, Dixon, Simon R, Goldstein, James A, Petersen, John L, Généreux, Philippe, Shah, Priti R, Crowley, Aaron, Nicholls, Stephen J, Mintz, Gary S, Muller, James E, and Weisz, Giora
- Subjects
Biomedical and Clinical Sciences ,Cardiovascular Medicine and Haematology ,Atherosclerosis ,Bioengineering ,Cardiovascular ,Heart Disease ,Heart Disease - Coronary Heart Disease ,4.2 Evaluation of markers and technologies ,Detection ,screening and diagnosis ,Aged ,Coronary Artery Disease ,Drug-Eluting Stents ,Female ,Follow-Up Studies ,Humans ,Lipid Metabolism ,Male ,Middle Aged ,Percutaneous Coronary Intervention ,Plaque ,Atherosclerotic ,Prospective Studies ,Registries ,Spectroscopy ,Near-Infrared ,Treatment Outcome ,intravascular ultrasound ,lipid-rich plaque ,near-infrared spectroscopy ,stent ,Cardiorespiratory Medicine and Haematology ,Public Health and Health Services ,Cardiovascular System & Hematology ,Cardiovascular medicine and haematology - Abstract
BackgroundAutopsy studies suggest that implanting stents in lipid-rich plaque (LRP) may be associated with adverse outcomes.ObjectivesThe purpose of this study was to evaluate the association between LRP detected by near-infrared spectroscopy (NIRS) and clinical outcomes in patients with coronary artery disease treated with contemporary drug-eluting stents.MethodsIn this prospective, multicenter registry, NIRS was performed in patients undergoing coronary angiography and possible percutaneous coronary intervention (PCI). Lipid core burden index (LCBI) was calculated as the fraction of pixels with the probability of LRP >0.6 within a region of interest. MaxLCBI4mm was defined as the maximum LCBI within any 4-mm-long segment. Major adverse cardiac events (MACE) included cardiac death, myocardial infarction, definite or probable stent thrombosis, or unplanned revascularization or rehospitalization for progressive angina or unstable angina. Events were subcategorized as culprit (treated) lesion-related, nonculprit (untreated) lesion-related, or indeterminate.ResultsAmong 1,999 patients who were enrolled in the COLOR (Chemometric Observations of Lipid Core Plaques of Interest in Native Coronary Arteries Registry), PCI was performed in 1,621 patients and MACE occurred in 18.0% of patients, of which 8.3% were culprit lesion-related, 10.7% were nonculprit lesion-related, and 3.1% were indeterminate during 2-year follow-up. Complications from NIRS imaging occurred in 9 patients (0.45%), which resulted in 1 peri-procedural myocardial infarction and 1 emergent coronary bypass. Pre-PCI NIRS imaging was obtained in 1,189 patients, and the 2-year rate of culprit lesion-related MACE was not significantly associated with maxLCBI4mm (hazard ratio of maxLCBI4mm per 100: 1.06; 95% confidence interval: 0.96 to 1.17; p = 0.28) after adjusting clinical and procedural factors.ConclusionsFollowing PCI with contemporary drug-eluting stents, stent implantation in NIRS-defined LRPs was not associated with increased periprocedural or late adverse outcomes compared with those without significant lipid.
- Published
- 2020